{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:33Z","timestamp":1761513513933,"version":"3.40.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"UAE University","award":["31M126"],"award-info":[{"award-number":["31M126"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejmech.2014.09.011","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T11:59:31Z","timestamp":1410004771000},"page":"578-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7021-1821","authenticated-orcid":false,"given":"Luca","family":"Lipani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalibor","family":"Odadzic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Weizel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes-Stephan","family":"Schwed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassem","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3336-1710","authenticated-orcid":false,"given":"Holger","family":"Stark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.09.011_bib1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","article-title":"Auto-inhibition of brain histamine release mediated by a novel class H3 of histamine receptor","volume":"302","author":"Arrang","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2014.09.011_bib2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35048583","article-title":"High constitutive activity of native H3 receptors regulates histamine neurons in brain","volume":"408","author":"Morisset","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2014.09.011_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/BF00717738","article-title":"Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors","volume":"340","author":"Schlicker","year":"1989","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.09.011_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01244933","article-title":"Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors","volume":"93","author":"Schlicker","year":"1993","journal-title":"J.\u00a0Neural. Transm. Gen. Sect."},{"key":"10.1016\/j.ejmech.2014.09.011_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF00182737","article-title":"Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex","volume":"337","author":"Schlicker","year":"1988","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.09.011_bib6","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1248\/bpb.31.2163","article-title":"Histamine H3 receptor antagonists go to clinics","volume":"31","author":"Sander","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2014.09.011_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.drudis.2009.02.011","article-title":"The histamine H3 receptor as a therapeutic drug target for CNS disorders","volume":"14","author":"Gemkow","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2014.09.011_bib8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1517\/14728220903188438","article-title":"Histamine H3 and H4 receptors as novel drug targets","volume":"18","author":"Tiligada","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejmech.2014.09.011_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2014.03.014","article-title":"Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties","volume":"77","author":"Sadek","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.011_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"HARMONY I study group, Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"11","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2014.09.011_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2741\/s279","article-title":"Histamine receptor subtypes: a century of rational drug design","volume":"4","author":"Walter","year":"2012","journal-title":"Front. Biosci. Sch. Ed."},{"key":"10.1016\/j.ejmech.2014.09.011_bib12a","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ddtec.2013.07.001","article-title":"Scaffold variations in amine warhead of histamine H3 receptor antagonists","volume":"4","author":"Wingen","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejmech.2014.09.011_bib12b","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2012.03.048","article-title":"Pharmacological characterization of A-960656, a histamine H\u2083 receptor antagonist with efficacy in animal models of osteoarthritis and neuropathic pain","volume":"684","author":"Cowart","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.09.011_bib13","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1039\/a803878c","article-title":"Synthesis of 1-[cis-3-(hydroxymethyl)cyclobutyl]-uracil, -thymine and -cytosine","volume":"1","author":"Frieden","year":"1998","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"10.1016\/j.ejmech.2014.09.011_bib14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/jm0110845","article-title":"Development of a new class of nonimidazole histamine H3 receptor ligands with combined inhibitory histamine N-methyltransferase activity","volume":"45","author":"Apelt","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.011_bib15","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/jm021084k","article-title":"Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds","volume":"46","author":"Mik\u00f3","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.011_bib16","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1021\/jm030185v","article-title":"A\u00a0new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines","volume":"46","author":"Apodaca","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.011_bib17","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1021\/jo061114h","article-title":"Revisiting nucleophilic substitution reactions: microwave-assisted synthesis of azides, thiocyanates, and sulfones in an aqueous medium","volume":"71","author":"Ju","year":"2006","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2014.09.011_bib18","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.bmcl.2009.02.110","article-title":"Fluorinated non-imidazole histamine H3 receptor antagonists","volume":"19","author":"Isensee","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.09.011_bib19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency: a useful metric for lead selection","volume":"9","author":"Hopkins","year":"2004","journal-title":"Drug Discov. Today"},{"year":"2001","series-title":"Osiris Property, Explorer","author":"Sander","key":"10.1016\/j.ejmech.2014.09.011_bib20"},{"key":"10.1016\/j.ejmech.2014.09.011_bib21","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/tx200211v","article-title":"Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety","volume":"24","author":"Meanwell","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2014.09.011_bib22","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1021\/jm201388p","article-title":"Impact of lipophilic efficiency on compound quality","volume":"55","author":"Tarcsay","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.011_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2014.09.011_bib24","first-page":"521","article-title":"Piperazine modification in 2,4,6-triaminopyrimidine derivatives as histamine H4 receptor ligands","volume":"68","author":"Schreeb","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2014.09.011_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/ml4004638","article-title":"Improving the plausibility of success with inefficient metrics","volume":"5","author":"Shultz","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.09.011_bib26","doi-asserted-by":"crossref","first-page":"9997","DOI":"10.1073\/pnas.96.18.9997","article-title":"The maximal affinity of ligands","volume":"96","author":"Kuntz","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2014.09.011_bib27","unstructured":"Drug-likeness and molecular property prediction. Available from: http:\/\/www.molsoft.com\/mprop\/."},{"key":"10.1016\/j.ejmech.2014.09.011_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejmech.2011.12.019","article-title":"Dibasic biphenyl H3 receptor antagonists: steric tolerance for a lipophilic side chain","volume":"48","author":"Bordi","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.011_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2012.02.049","article-title":"Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studies","volume":"52","author":"Ceras","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.09.011_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0928-0987(01)00106-3","article-title":"Influence of imidazole replacement in different structural classes of histamine H3-receptor antagonists","volume":"13","author":"Meier","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2014.09.011_bib31a","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/ml300383n","article-title":"Bodilisant e a novel fluorescent, highly affine histamine H3 receptor ligand","volume":"4","author":"Tomasch","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.09.011_bib31b","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/cmdc.200600270","article-title":"Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands","volume":"2","author":"Amon","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2014.09.011_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jlac.18510770104","article-title":"About the theory of the formation of ethers","volume":"77","author":"Williamson","year":"1851","journal-title":"Ann. Chem. Pharm."},{"key":"10.1016\/j.ejmech.2014.09.011_bib33","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.09.011_bib34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejphar.2010.12.033","article-title":"Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3\/H4 receptor ligands","volume":"654","author":"Kottke","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2014.09.011_bib35","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/bi802050d","article-title":"High constitutive activity and a G-protein-independent high-affinity state of the human histamine H4-receptor","volume":"48","author":"Schneider","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2014.09.011_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci6003515","article-title":"ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules?","volume":"47","author":"Hou","year":"2007","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2014.09.011_bib37","unstructured":"Molinspiration software or free molecular property calculation services, (2 screens), Available from URL: www.molinspiration.com\/cgi-bin\/properties, (last accessed 07.06.13.)."},{"key":"10.1016\/j.ejmech.2014.09.011_bib38","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry,","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414008290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414008290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T21:25:57Z","timestamp":1538256357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414008290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":40,"alternative-id":["S0223523414008290"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.09.011","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}